Laman UtamaCMXHF • OTCMKTS
CSL Ltd
$170.75
29 Jan, 12:18:35 PG GMT-5 · USD · OTCMKTS · Penafian
SahamSekuriti tersenarai ASIbu pejabat di AU
Tutup sebelumnya
$170.75
Julat tahun
$162.94 - $210.49
Permodalan pasaran
134.29B AUD
Bilangan Purata
439.00
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
ASX
Markah Perubahan Iklim CDP
C
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(USD)Jun 2024Perubahan T/T
Hasil
3.37B10.14%
Perbelanjaan pengendalian
1.05B12.78%
Pendapatan bersih
370.50J29.77%
Margin untung bersih
10.9817.81%
Pendapatan bagi setiap syer
EBITDA
788.00J3.01%
Kadar cukai berkesan
20.28%
Jumlah aset
Jumlah liabiliti
(USD)Jun 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
1.66B7.04%
Jumlah aset
38.02B4.93%
Jumlah liabiliti
18.62B1.16%
Jumlah ekuiti
19.40B
Syer tertunggak
483.25J
Harga kepada buku
4.75
Pulangan pada aset
4.22%
Pulangan pada modal
5.08%
Perubahan bersih dalam tunai
(USD)Jun 2024Perubahan T/T
Pendapatan bersih
370.50J29.77%
Tunai daripada operasi
847.50J4.57%
Tunai daripada pelaburan
-278.50J22.53%
Tunai daripada pembiayaan
-235.00J43.37%
Perubahan bersih dalam tunai
316.00J1,139.22%
Aliran tunai bebas
348.19J93.30%
Perihal
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Diasaskan
1916
Tapak web
Pekerja
32,698
Temui lagi
Pengguna juga mencari
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama